Pricing and Reimbursement Strategies for Medical Devices

NEW YORK, March 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pricing and Reimbursement Strategies for Medical Devices

http://www.reportlinker.com/p0799254/Pricing-and-Reimbursement-Strategies-for-Medical-Devices.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Facility

The routes to medical devices being purchased within public healthcare systems vary significantly between countries. The major markets of the US and Europe are examined in this report, analyzing the strategies being used by medical device manufacturers to sell and succeed within them. Understand the healthcare structure in the US, Germany, France, Italy, Spain, and the UK. Identify the most prominent factors influencing the reimbursement environment globally and on a country-specific basis. Gain insight into the reimbursement routes for three product sectors in each country. Compare the differences in pricing and market entry strategies that work best in each country. Gain recommendations for how pricing and reimbursement strategies should be developed for optimum results. Diagnosis related groupings (DRGs) are taking in an ever-increasing role in the payment processes applied to medical devices. DRGs are becoming more refined and top-up payments are being rationalized. In the US, price skimming is the most frequently used strategy in the medical device market, but market segmentation should be used to assess if other strategies, such as penetration pricing, would be more apt in particular sectors. Within each country regional differences between purchasing and pricing are increasing. Pricing should be determined by examining the requirements of the purchasing institution and regional requirements, but caution should be taken not to undervalue the product and to be aware of the global strategy. It is easier to lower a price than to raise it. What is the nature of the market environment across Europe and in the US? How are the reimbursement sectors divided? Who pays for medical devices and what are the decision-making processes involved? What role do national health frameworks play, and which government bodies have the greatest influence on pricing and reimbursement? What is appropriate pricing, and how is the correct balance achieved?

About the author

Disclaimer

EXECUTIVE SUMMARY

An overview of pricing

An overview of reimbursement

Pricing and reimbursement in the US

An overview of Europe

France

Germany

Italy

Spain

The UK

Conclusions for global pricing and market access strategies

An overview of pricing

Summary

Introduction

Pricing and value

Pricing strategies

Price sensitivity

Methods of assessing price sensitivity

Economy pricing

Price skimming

Penetration pricing

Pre-emptive pricing

Extinction pricing

Premium or prestige pricing

Cost-based pricing

Cost-plus pricing

Experience-curve pricing

Pricing differentiation

Competitive parity

Market segmentation

The realities of pricing strategies

An overview of reimbursement

Summary

Introduction

Reimbursement mechanisms

The importance of classification

The importance of health technology assessment

Pricing and reimbursement in the US

Summary

Introduction

Market environment

Medicaid

Procurement

Reimbursement and coding

Key pricing and market access issues

FDA and CMS considerations

Distribution

An overview of Europe

Summary

Introduction

Procurement

Reimbursement and coding

France

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Ambulatory

Key pricing and market access issues

Strategies

Company examples

Useful addresses

Germany

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Ambulatory

Key pricing and market access issues

Strategies

Company examples

Addresses

Italy

Summary

Introduction

Market environment

Hospital corporations

USL-managed public hospitals

Agreed private clinics

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Agreed private clinics

Key pricing and market access issues

Strategies

Company examples

Addresses

Spain

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Capital equipment

Non-capital equipment

Private clinics

Key pricing and market access issues

Strategies

Company examples

Addresses

The UK

Summary

Introduction

Market environment

Procurement

Reimbursement and coding

Non-capital equipment

Private clinics

Key pricing and market access issues

Strategies

Company examples

Addresses

Conclusions for global pricing and market access strategies

Summary

Introduction

Local optimization

Global coordination

Appendix

Scope

Methodology

Primary research

Secondary research

Glossary/Abbreviations

References

Companies mentioned

Aalberts Industries N.V., ERGO Versicherungsgruppe AG, Groupama S.A., Hutchison 3G UK Limited, Imperial Tobacco Group PLC, Informa plc, Johnson & Johnson, Kaiser Permanente, McKesson Corporation, Metro AG, Publicis Groupe SA, Schindler Holding Ltd., Siemens Healthcare, Sistema JSFC

To order this report:

Medical Facility Industry: Pricing and Reimbursement Strategies for Medical Devices

More Market Research Report

Check our Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker